Dasatinib in recurrent glioblastoma: failure as a teacher
Neuro Oncol
.
2015 Jul;17(7):910-1.
doi: 10.1093/neuonc/nov086.
Epub 2015 May 10.
Authors
David Schiff
1
,
Jann Sarkaria
1
Affiliation
1
University of Virginia Neuro-Oncology Center, Charlottesville, Virginia (D.S.); Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota (J.S.).
PMID:
25964312
PMCID:
PMC5762007
DOI:
10.1093/neuonc/nov086
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antineoplastic Agents / therapeutic use*
Brain Neoplasms / drug therapy*
Dasatinib / therapeutic use*
Glioblastoma / drug therapy*
Humans
Male
Substances
Antineoplastic Agents
Dasatinib